Dataset Information


Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype.

ABSTRACT: Monosomal karyotype (MK) defined by either ?2 autosomal monosomies or single monosomy with at least one additional structural chromosomal abnormality is associated with a dismal prognosis in patients with acute myeloid leukemia (AML). It was detected in 174 of 3041 AML patients in South Korean Registry. A total of 119 patients who had received induction therapy were finally analyzed to evaluate the predictive factors for a positive prognosis. On multivariate analysis, single monosomy, the absence of abn(17p), ?10% of cells with normal metaphase and the achievement of a complete remission (CR) after induction therapy were significant factors for more favorable outcomes. Especially, single monosomy remained as a significantly independent prognostic factor for superior survival in both patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT) in CR and who did not. Allo-HSCT in CR improved overall survival significantly only in patients with a single monosomy. Our results suggest that MK-AML may be biologically different according to the karyotypic subtype and that allo-HSCT in CR should be strongly recommended to patients with a single monosomy. For other patients, more prudent treatment strategies should be examined. Furthermore, the biological mechanism by which a single monosomy influences survival should be investigated.


PROVIDER: S-EPMC4635193 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5573653 | BioStudies
1000-01-01 | S-EPMC3156042 | BioStudies
1000-01-01 | S-EPMC3709629 | BioStudies
2020-01-01 | S-EPMC7221314 | BioStudies
2018-01-01 | S-EPMC5797220 | BioStudies
2017-01-01 | S-EPMC5729330 | BioStudies
2019-01-01 | S-EPMC6901822 | BioStudies
2020-01-01 | S-EPMC7316846 | BioStudies
2019-01-01 | S-EPMC6539946 | BioStudies
1000-01-01 | S-EPMC6181529 | BioStudies